Download MendeleyIdentification of 2-amino-5-aryl-pyrazines as inhibitors of human lactate dehydrogenase.
Fauber, B.P., Dragovich, P.S., Chen, J., Corson, L.B., Ding, C.Z., Eigenbrot, C., Giannetti, A.M., Hunsaker, T., Labadie, S., Liu, Y., Liu, Y., Malek, S., Peterson, D., Pitts, K., Sideris, S., Ultsch, M., Vanderporten, E., Wang, J., Wei, B., Yen, I., Yue, Q.(2013) Bioorg Med Chem Lett 23: 5533-5539
- PubMed: 24012183
- DOI: https://doi.org/10.1016/j.bmcl.2013.08.060
- Primary Citation of Related Structures:
4M49 - PubMed Abstract:
A 2-amino-5-aryl-pyrazine was identified as an inhibitor of human lactate dehydrogenase A (LDHA) via a biochemical screening campaign. Biochemical and biophysical experiments demonstrated that the compound specifically interacted with human LDHA. Structural variation of the screening hit resulted in improvements in LDHA biochemical inhibition and pharmacokinetic properties. A crystal structure of an improved compound bound to human LDHA was also obtained and it explained many of the observed structure-activity relationships.
Organizational Affiliation:
Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA. Electronic address: benjampf@gene.com.
